Joao Incio is a physician-scientist and the General Partner at Biovance Capital, focusing on early-stage biotech ventures across Europe. With a background in molecular medicine and oncology from the University of Oxford, he is described by colleagues as having an "exceptional mind" and being an encouraging and challenging leader.
Deeply connected to his Portuguese heritage, Joao previously served as President of the Portuguese American Post-Graduate Society. He maintains a keen interest in European economics and innovation, believing its a time for optimism in the region. His professional interests include GE HealthCare and IBM.
Unique fact: A scientist at heart, Joao holds patents for novel drug delivery methods and new uses of metformin, an anti-diabetic medication.
Read the full overview →They like to take decisions independently and do not seek others' support often. It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.